Northwire Canada EditionSunday, July 12, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
M&A / Property

Tilray Medical, CC Pharma, and 14U Pharma Announce Strategic Alliance with "gesund leben" Cooperation and Alliance Healthcare Deutschland to Accelerate Market Expansion and Strengthen Pharmacy Access Across Germany

By The Northwire Desk — AI Analysis Mar 12, 2026 · 07:00 TLRY · 9.83 TILRAY BRANDS, INC. J
TLRY · Price

Executive Summary

  • Tilray Pharma (Tilray Brands’ pharmaceutical division) announced a strategic partnership with Tilray Medical, CC Pharma, 14U Pharma and the “gesund leben” cooperation operated by Alliance Healthcare Deutschland.
  • Effective April 1 2026 the partners will combine distribution networks to supply ~3,600 German pharmacies with prescription medicines, parallel‑import discounted drugs and Tilray’s medical cannabis portfolio.
  • The alliance gives CC Pharma preferred access to >20% of German pharmacies and expands its reach to over 16,000 pharmacies nationwide, strengthening Tilrow’s market presence in Germany.

Key Details

  • Partnership Scope: Collaboration among Tilray Medical, CC Pharma, 14U Pharma and Alliance Healthcare Deutschland’s “gesund leben” network.
  • Effective Date: April 1 2026.
  • Network Reach: “gesund leben” cooperation includes approximately 3,600 member pharmacies; Alliance Healthcare operates 27 logistics centres serving >10,000 pharmacies daily.
  • Product Offering: Prescription medications (Rx), discounted parallel‑import medicines, and Tilray Medical’s medical cannabis portfolio.
  • Benefits to Pharmacies: Competitive purchasing terms, digital/priority access, expanded product availability, operational efficiency services, marketing support, and customized assistance.
  • CC Pharma Access: Preferred access to >20% of German pharmacies; currently supports >16,000 pharmacies across Germany.
  • Strategic Rationale (CEO Quote): “Germany remains one of the most important and dynamic healthcare markets in Europe… scaling our German operations, expanding pharmacy access, and creating an even more powerful platform for long‑term growth.” – Rajnish Ohri, President, International, Tilray Brands.
  • CC Pharma Comment (MD Quote): Emphasized new level of partnership to set “new standards in access, service, and innovation for pharmacies and patients across Germany.” – Mathias Bossen, Managing Director, CC Pharma.

Notable Quotes

“Germany remains one of the most important and dynamic healthcare markets in Europe… we are stronger together — scaling our German operations, expanding pharmacy access, and creating an even more powerful platform for long‑term growth.” – Rajnish Ohri, President, International, Tilray Brands

“Our long‑standing partnership with Alliance Healthcare Deutschland is being taken to a new level through this strategic cooperation… setting new standards in access, service, and innovation for pharmacies and patients across Germany.” – Mathias Bossen, Managing Director, CC Pharma

Read the original news release →

More from TILRAY BRANDS, INC. J

Jun 29, 2026 · 17:09

Strategic Canadian medical cannabis platform add-on; financials undisclosed as stock digests post-BrewDog integration headwinds.

M&A / Property Jun 24, 2026 · 08:13

BrewDog summer promos fail to offset sustained post-acquisition valuation compression and guidance caution.

Production / Operations Jun 22, 2026 · 09:50

BrewDog Bars Draw Record Fan Turnout as Global Tournament Fever Drives Double-Digit Growth

Production / Operations Jun 18, 2026 · 07:30

Breckenridge Distillery Releases Limited Single Barrel Bourbon Collection

Other Jun 18, 2026 · 07:00

Incremental SKU additions to a beverage portfolio already priced for execution risk; no near-term financial inflection.

Other Jun 17, 2026 · 07:00

BrewDog integration and beverage margin pressure overshadow cannabis growth; stock discounts guidance achievability

Other